Abstract
This paper aims to compare the results of single-joint knee vs hip hyaluronic acid (HA) injections in patients with osteoarthritis (OA) involving both the knee and hip joints. Thirty-eight patients who were diagnosed to have both hip and knee OA were enrolled. Patients were divided into two groups to receive HA injection three times at 1-week intervals either to the hip or knee joints. Pain level during activities and rest was measured by using visual analog scale (VAS). Western Ontario and McMaster University Osteoarthritis Index (WOMAC 5-point Likert 3.0) was also used prior to the injections and 1 month after the 3rd injection. In the knee injection group, the intragroup analysis revealed significant improvements in VAS activity pain, VAS rest pain, and WOMAC pain values following injection when compared with preinjection values, while no significant difference was detected in WOMAC stiffness, WOMAC physical function, and WOMAC total values. In the hip injection group, VAS activity pain, VAS rest pain, WOMAC pain, WOMAC stiffness, WOMAC physical function, and WOMAC total values showed significant improvement after the injection when compared with preinjection values. Although statistically not significant (p > 0.05), the comparison of the differences (preinjection–postinjection) between the groups demonstrated higher values in the hip injection group. We imply that intra-articular single-joint HA injections either to the knee or hip joints in OA patients with involvement of both of these joints are effective with regard to pain and functional status.
Similar content being viewed by others
References
Zhang Y, Jordan JM (2008) Epidemiology of osteoarthritis. Rheum Dis Clin North Am 34:515–529
Bierma-Zeinstra SM, Koes BW (2007) Risk factors and prognostic factors of hip and knee osteoarthritis. Nat Clin Pract Rheumatol 3:78–85
Diracoglu D (2007) Intra-articular hyaluronic acid in the management of osteoarthritis. Turk J Phys Med Rehab 53:154–159
Migliore A, Granata M (2008) Intra-articular use of hyaluronic acid in the treatment of osteoarthritis. Clin Interv Aging 3:365–369
Das SK, Farooqi A (2008) Osteoarthritis. Best Pract Res Clin Rheumatol 22:657–675
Jordan KM, Arden NK, Doherty M et al (2003) EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62:1145–1155
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (2000) Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 43:1905–1915
van den Bekerom MP, Lamme B, Sermon A, Mulier M (2008) What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature. Arch Orthop Trauma Surg 128:815–823
Aggarwal A, Sempowski IP (2004) Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. Can Fam Physician 50:249–256
Altman R, Asch E, Bloch D, Bole G et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee, diagnostic and therapeutic criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049
Altman R, Alarcon G, Appelrouth D (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505–514
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502
Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthritis Cartilage 13:28–33
Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM (1995) Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 38:1134–1141
Shoor S (2006) Review: viscosupplementation for knee osteoarthritis reduces pain and improves function. Evid Based Med 11:12
Takahashi K, Goomer RS, Harwood F, Kubo T et al (1999) The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 7:182–190
Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM (2006) High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 14:1237–1247
Wang CT, Lin J, Chang CJ, Lin YT, Hou SM (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A:538–545
Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Müllner M (2005) Intra articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172:1039–1043
Bragantini A, Molinaroli F (1994) A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res 55:319–330
Migliore A, Tormenta S, Massafra U et al (2008) Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. Curr Med Res Opin 24:1309–1316
Conrozier T, Bertin P, Bailleul F et al (2006) Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study. Joint Bone Spine 73:705–709
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dıraçoğlu, D., Alptekin, K., Teksöz, B. et al. Knee vs hip single-joint intra-articular hyaluronic acid injection in patients with both hip and knee osteoarthritis: a pilot study. Clin Rheumatol 28, 1021–1024 (2009). https://doi.org/10.1007/s10067-009-1199-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-009-1199-7